Eli Lilly is airing an ad during the Academy Awards urging customers to adopt a health skepticism when marketed drug brands that are not FDA-approved.
Last week, a federal court in Maryland issued a memorandum opinion and a nationwide preliminary injunction preventing enforcement of ...
1h
Zacks.com on MSNPharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & MoreEli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.
Following a flurry of activity at this month’s meeting of the European Medicines Agency’s Committee for Medicinal Products ...
Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.
Iowa girls’ high school state basketball tournament smorgasbord: Brackets, predictions, top players and more for the coming ...
Eli Lilly said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its Jaypirca cancer drug in certain patients with chronic lymphocytic ...
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...
Pope Francis reaches 2-week mark at hospital with pneumonia. Doctors suggest he's overcome the worst
The Vatican's early Friday update also suggested a level of normalcy and routine as the 88-year-old pope continues recovering ...
That's a potential steal. The average stock in the Health Care Select Sector SPDR Fund trades at a multiple of just under 18 ...
For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results